Author: Dimitri Semizarov
Edition: 1
Publisher: Wiley
Binding: Hardcover
ISBN: 0470096047
Genomics in Drug Discovery and Development
Early characterization of toxicity and efficacy would significantly impact the overall productivity of pharmaceutical R&D and reduce drug candidate attrition and failure. Medical books Genomics in Drug Discovery and Development. By describing the available platforms and weighing their relative advantages and disadvantages, including microarray data analysis, Genomics in Drug Discovery and Development introduces readers to the biomarker, pharmacogenomic, and toxicogenomics toolbox Medical books Genomics in Drug Discovery and Development (Hardcover). Early characterization of toxicity and efficacy would significantly impact the overall productivity of pharmaceutical RD and reduce drug candidate attrition and failure. By describing the available platforms and weighing their relative advantages and disadvantages, including microarray data analysis, Genomics in Drug Discovery and Development introduces readers to the biomarker, pharmacogenomic, and toxicogenomics toolbox. The authors provide a valuable resource for pharmaceutical discovery scientists, preclinical drug safety department personnel, regulatory personnel, discovery toxicologists, and safety scientists, drug development...
Download link for Genomics in Drug Discovery and Development
Early characterization of toxicity and efficacy would significantly impact the overall productivity of pharmaceutical RD and reduce drug candidate attrition and failure. By describing the available platforms and weighing their relative advantages and disadvantages, including microarray data analysis, Genomics in Drug Discovery and Development introduces readers to the biomarker, pharmacogenomic, and toxicogenomics toolbox. The authors provide a valuable resource for pharmaceutical discovery scientists, preclinical drug safety department personnel, regulatory personnel, discovery toxicologists,
Early characterization of toxicity and efficacy would significantly impact the overall productivity of pharmaceutical R&D and reduce drug candidate attrition and failure. By describing the available platforms and weighing their relative advantages and disadvantages, including microarray data analysis, Genomics in Drug Discovery and Development introduces readers to the biomarker, pharmacogenomic, and toxicogenomics toolbox. The authors provide a valuable resource for pharmaceutical discovery scientists, preclinical drug safety department personnel, regulatory personnel, discovery toxicologists
Store Search search Title, ISBN and Author Genomics in Drug Discovery and Development by Dimitri Semizarov, Eric Blomme Estimated delivery 3-12 business days Format Hardcover Condition Brand New Early characterization of toxicity and efficacy would significantly impact the overall productivity of pharmaceutical RD and reduce drug candidate attrition and failure. Publisher Description Early characterization of toxicity and efficacy would significantly impact the overall productivity of pharmace
Categories: Genetic toxicology, Drug development, DNA microarrays. Contributors: Dimitri Semizarov - Author. Format: Hardcover
Medical Book Genomics in Drug Discovery and Development
By describing the available platforms and weighing their relative advantages and disadvantages, including microarray data analysis, Genomics in Drug Discovery and Development introduces readers to the biomarker, pharmacogenomic, and toxicogenomics toolbox. The authors provide a valuable resource for pharmaceutical discovery scientists, preclinical drug safety department personnel, regulatory personnel, discovery toxicologists, and safety scientists, drug development professionals, and pharmaceutical scientists.
